Abstract
Background: The eosin-5′-maleimide (EMA) binding test is a flow cytometric test widely used to detect hereditary spherocytosis (HS). EMA binds to plasma membrane proteins of red blood cells (RBCs), mainly to band 3 protein. The mean fluorescence of EMA-stained RBCs in HS patients is lower when compared with control RBCs due to the decreased amount of target proteins. EMA dye in aqueous solution is sensitive to light and high temperature. Its fluorescence can decrease when exposed to light or ambient temperatures higher than 4°C. The aim of the study was to evaluate the stability of fluorescence readings of EMA-labeled RBCs over a period of 24 h.
Methods: The EMA test was performed in peripheral blood from 35 patients with microcytic anemia (five with HS, and 30 without HS). Peripheral blood samples were stained immediately after blood collection and analyzed using a flow cytometer at three time points: 0, after 1 and 24 h of storage at 4°C in the darkness. The results are presented as the percentage of normal control RBCs fluorescence. Flow cytometric studies were performed with Cytomics FC500 (Beckman Coulter, USA).
Results: In HS patients the mean result of the test reached 66.72%±9.26% of normal controls, and in non-HS patients the EMA result was 99.48%±5.03% of normal control cells. The results of patients with HS were 66.72%±9.26%, 66.90%±10.24% and 67.86%±11.31% at 0 h, and after 1 and 24 h of storage, respectively. The results obtained from non-HS patients at time 0, after 1 and 24 h of storage reached 99.48%±5.03%, 99.49%±5.34% and 99.78%±6.13%, respectively. There was no difference between the results from each time point in samples from patients with or without HS.
Conclusions: Results of the EMA binding test do not depend on storage time of stained samples when stored at 4°C up to 24 h after staining.
References
1. Bolton-Maggs PH, Langer JC, Iolascon A, Tittensor P, King M-J. Guidelines for the diagnosis and management of hereditary spherocytosis – 2011 update. Br J Haematol 2011;156:37–49.10.1111/j.1365-2141.2011.08921.xSearch in Google Scholar
2. Shah S, Vega R. Hereditary spherocytosis. Pediatr Dyplom 2005;9:47–53.Search in Google Scholar
3. Stoya G, Gruhn B, Vogelsang H, Baumann E, Linss W. Flow cytometry as a diagnostic tool for hereditary spherocytosis. Acta Haematol 2006;116:186–91.10.1159/000094679Search in Google Scholar PubMed
4. Perrotta S, Gallagher P, Mohandas N. Hereditary spherocytosis. Lancet 2008;372:1411–26.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000260228200028&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f310.1016/S0140-6736(08)61588-3Search in Google Scholar
5. King M-J, Behrens J, Rogers C, Flynn C, Greewood D, Chambers K. Rapid flow cytometric test for the diagnosis of membrane cytoskeleton-associated haemolytic anaemia. Br J Haematol 2000;111:924–33.Search in Google Scholar
6. D’Alcamo E, Agrigento V, Sclafani S, Vitrano A, Cuccia L, Maggio A, et al. Peliability of EMA binding test in the diagnosis of hereditary spherocytosis in Italian patients. Acta Heamatol 2011;125:136–40.10.1159/000322253Search in Google Scholar PubMed
7. Crisp RL, Solari L, Vota D, Garcia E, Miguez G, Chamorro ME, et al. A prospective study to assess the predictive value for hereditary spherocytosis using five laboratory tests (cryohemolysis test, eosin-5’-maleimide flow cytometry, osmotic fragility test, autohemolysis test, and SDS-PAGE) on 50 hereditary spherocytosis families in Argentina. Ann Hematol 2011;90:625–34.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000290270100002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f310.1007/s00277-010-1112-0Search in Google Scholar PubMed
8. Crisp RL, Solari L, Gammella D, Schvartzman GA, Rapetti MC, Donato H. Use of capillary blood to diagnose hereditary spherocytosis. Pediatr Blood Cancer 2012;doi:10.1002/pbc.24157.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000309752400027&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f310.1002/pbc.24157Search in Google Scholar PubMed
9. Eber S, Lux SE. Hereditary spherocytosis – defects in proteins that connect the membrane skeleton to the lipid bilayer. Semin Hematol 2004;41:118–41.10.1053/j.seminhematol.2004.01.002Search in Google Scholar PubMed
10. Barcellini W, Bianchi P, Fermo E, Imperiali FG, Marcello AP, Vercellati C, et al. Hereditary red cell membrane defects: diagnostic and clinical aspects. Blood Transfus 2011;9:274–7.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000293428600005&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Search in Google Scholar PubMed
11. Liem RI, Gallagher PG. Molecular mechanisms in the inherited red cell membrane disorders. Drug Discov Today 2005;2:539–45.10.1016/j.ddmec.2005.11.004Search in Google Scholar
12. Webb D. Disorders of the red cell membrane. Curr Paediatr 2005;15:40–3.10.1016/j.cupe.2004.10.006Search in Google Scholar
13. Bolton-Maggs PH. The diagnosis and management of hereditary spherocytosis. Bailliere’s Clin Haematol 2000;13:327–42.10.1053/beha.2000.0081Search in Google Scholar PubMed
14. Diakowski W, Grzybek M, Sikorski AF. Protein 4.1, a component of the erythrocyte membrane skeleton and its related homologue proteins forming the protein 4.1/FERM superfamily. Folia Histochem Cytobiol 2006;44:231–48.Search in Google Scholar
15. Kar P, Mishra P, Pati HP. Evaluation of eosin-5-maleimide flow cytometric test in diagnosis of hereditary spherocytosis. Int J Lab Hematol 2010;32:8–16.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000275511300002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f310.1111/j.1751-553X.2008.01098.xSearch in Google Scholar
16. Bianchi P, Fermo E, Vercellati C, Marcello AP, Porretti L, Cortelezzi A, et al. Diagnostic power of laboratory tests for hereditary spherocytosis: a comparison study in 150 patients grouped according to molecular and clinical characteristics. Haematologica 2012;97:516–23.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000303241600010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f310.3324/haematol.2011.052845Search in Google Scholar
17. Kedar PS, Colah RB, Kulkarni S, Ghosh K, Mohanty D. Experience with eosin-5’-maleimide as a diagnostic tool for red cell membrane cytoskeleton disorders. Clin Hematol Lab 2003;25:373–6.10.1046/j.0141-9854.2003.00557.xSearch in Google Scholar
18. King MJ, Smythe JS, Mushens R. Eosin-5-maleimide binding to band 3 and Rh-related proteins forms the basis of a screening test for hereditary spherocytosis. Br J Haematol 2004;124:106–13.10.1046/j.1365-2141.2003.04730.xSearch in Google Scholar
19. King M-J, Jepson MA, Guest A, Mushens R. Detection of hereditary pyropoiliocytosis by the eosin-5-maleimide (EMA)-binding test is attributable to a marked reduction in EMA-reactive transmembrane proteins. Int J Lab Hematol 2011;33:205–11.10.1111/j.1751-553X.2010.01270.xhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000288127900016&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Search in Google Scholar
20. Schopfer LW, Salhany JM. Spectroscopic and kinetic characterization of eosin-5-maleimide. Anal Biochem 1998;257:139–48.10.1006/abio.1998.2575Search in Google Scholar
21. King MJ, Telfer P, Mackinnon H, Langabeer L, McMahon C, Darbyshire P, et al. Using the eosin-5-maleimide binding test in the differential diagnosis of hereditary spherocytosis and herediatry pyropoikilicytosis. Cytometry Part B 2008;74B: 244–50.10.1002/cyto.b.20413http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000256870500006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Search in Google Scholar
22. Szmydki-Baran A, Adamowicz-Salach A, Gołębiewska-Staroszczyk S, Stelmaszczyk-Emmel A, Górska E, Potapińska O. Evaluation of long-term blood sample storage and its influence on result of EMA binding test analysis. Pediatr Polska 2009;84:423–5.10.1016/S0031-3939(09)70105-2Search in Google Scholar
23. Yamakose H, Sato Y, Suzuki Y. Interaction of eosin-5-maleimide with band 3 of human erythrocytes. Biol Pharm Bull 1993;16:1282–7.10.1248/bpb.16.1282Search in Google Scholar
24. Majima E, Goto S, Hori H, Shinohara Y, Hong YM, Hiroshi T. Stabilities of the fluorescent SH-reagent eosin-5-maleimide and its adducts with sulfhydryl compounds. Biochim Biophys Acta 1995;1243:336–42.10.1016/0304-4165(94)00159-USearch in Google Scholar
25. Cobb CE, Beth AH. Identification of the eosinyl-5-maleimide reaction site on the human erythrocyte anion-exchange protein: overlap with the reaction sites of other chemical probes. Biochemistry 1990;29:8283–90.10.1021/bi00488a012Search in Google Scholar PubMed
26. Żarlak W, Adamowicz-Salach A, Ciepiela O, Kotuła I, Szmydki-Baran A, Demkow U. Usefulness of laboratory diagnostics in hereditary spherocytosis. Diagn Lab 2012;48: 25–31. [Polish].Search in Google Scholar
27. Girodon F, Garcon L, Bergoin E, Largier M, Delaunay J, Fénéant-Thibault M, et al. Usefulness of the eosin-5’-maleimide cytometric method as a first-line screening test for the diagnosis of hereditary spherocytosis: comparison with ektacytometry and protein electrophoresis. Br J Haematol 2008;140:468–70.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000252556400014&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f310.1111/j.1365-2141.2007.06944.xSearch in Google Scholar PubMed
©2013 by Walter de Gruyter Berlin Boston